Cassava Sciences stock price forecast for Q3 after shares rally 27%

Wednesday, 21 July 2021, 23:23:11

Meme stock Cassava Sciences Inc. (NASDAQ:SAVA) shares surged more than 27% on Wednesday after revealing plans to present data on its Alzheimers drug, Simufilam, on 29th July. Cassava will read out its interim analysis on a 9-month treatment with Simulflam at the 2021 Alzheimers Association International Conference (AAIC) in Denver. It will cover safety and []
The post Cassava Sciences stock price forecast for Q3 after shares rally 27% appeared first on Invezz.
— Invezz

Cassava Sciences Inc Shares Close the Day 10.1% Lower – Daily Wrap

Saturday, 10 July 2021, 03:07:12
Cassava Sciences Inc (SAVA) shares closed today 10.1% lower than it did at the end of yesterday. The stock is currently flat year-to-date, up 2758.8% over the past 12 months, and up 508.0% over the past five years. Today, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 1.1%. Trading Activity Shares traded as high as $113.27 and as low as $86.14 this week.Trading volume this week was 12.6% higher than the 10-day average and 32.7% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and beats it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date is the same as the peer average. The company's stock price performance over the past 12 months beats the peer average by -15179.0%

— Kwhen Finance

ENL Land Ltd (Mauritius) declared a final dividend of 0.5 MUR per share

Monday, 5 July 2021, 12:25:36
ENL Land Ltd has declared a dividend. The following are the details related to the dividend: Declaration date 30/06/2021 Ex-Dividend date 15/07/2021 Record date 19/07/2021 Payment date 06/08/2021 Dividend amount per share 0.5 MUR
— African Financials

Cassava Sciences Consensus Indicates Potential 146.9% Upside

Thursday, 24 June 2021, 12:25:05
Cassava Sciences found using ticker (SAVA) now have 3 analysts in total covering the stock. The consensus rating is ”Buy”. The range between the high target price and low target price is between 24 and 14 with the average target price sitting at 19.33. With the stocks previous close at 7.83 this would indicate that there is a potential upside of 146.9%. The day 50 moving average is 8.38 and the 200 day moving average is 6.22. The company has a market cap of $265m. Visit the company website at: /> [stock_market_widget type=”chart” symbol=”SAVA” chart=”bar” range=”6mo” interval=”1d” line-color=”rgb(49, 125, 189)”] Cassava Sciences, a clinical stage biotechnology company, develops drugs for nervous system disorders. Its lead therapeutic product candidate is PTI-125, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer”s disease. The company was formerly known as Pain Therapeutics and changed its name to Cassava Sciences in March 2019.
— DirectorsTalk

Why Cassava Sciences Shares Are Moving Today

Monday, 21 June 2021, 20:26:04
Cassava Sciences Inc (NASDAQ: SAVA ) shares are trading higher by Full story available on Benzinga.com
— Benzinga